...

 
Cannvas.Me
Sign Up For Free
  • Post Time Posted July 09, 2018
The Food and Drug Administration (FDA) has rejected a call by an anti-marijuana legalization group to list cannabis on its list of over-the-counter drugs that are generally seen as unsafe or ineffective. 

Companies on the FDA’s list, officially called a “negative monograph”, are legally prohibited from marketing over-the-counter drugs without prior approval by the FDA. 

The request came from Drug Watch International, a group that alerts consumers of pharmaceutical drug side effects and that is also opposed to marijuana legalization. 

Janet Woodcock, the director of the FDA’s Center for Drug Evaluation, responded to the group by saying that such enforcement is “not necessary for the protection of public health”. Woodcock went onto say that the FDA will however, continue to take “enforcement action against illegal marketing of unapproved cannabis products”. 

Source: https://www.consumeraffairs.com/news/fda-rejects-proposal-to-intensify-crackdowns-on-cannabis-industry-070918.html


This article is now marked as read.

Was this article helpful?

Review this article to help us continue creating and sharing relevant content.

Please note it may take up to two business days for reviews to be validated and published.

Reviews

Review this article to help us continue creating and sharing relevant content.

Write Review

Would you like to
make this review public?

Please disable your ad blocker to avoid issues using social plugins on Cannvas.Me. Thanks.
Close